Kathleen Laporte Phoenix Biotech Acquisition Corp. (PBAXU) insider trading activity

Kathleen Laporte is Director of PHOENIX BIOTECH ACQUISITION CORP.. Currently has a direct ownership of 5,828 shares of PBAXU, which is worth approximately $0. The most recent transaction as insider was on Feb 14, 2024, when has been sold 5,828 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.83K

0% 3M change

n/a 12M change

Total Value Held $0

KATHLEEN LAPORTE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 14 2024	BUY Other acquisition or disposition	-	5,828 Added 50.0%	5,828 Common Stock

Also insider at

PRPO

Precipio, Inc. Healthcare

Director

BOLT

Bolt Biotherapeutics, Inc. Healthcare

ETNB

89bio, Inc. Healthcare

FIXX

Homology Medicines, Inc. Healthcare